News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
168,471 Results
Type
Article (2764)
Company Profile (6)
Press Release (165701)
Section
Business (53990)
Career Advice (100)
Deals (10952)
Drug Delivery (7)
Drug Development (23667)
Employer Resources (10)
FDA (4242)
Job Trends (4124)
News (93105)
Policy (7567)
Tag
Academia (329)
Accelerated approval (14)
Adcomms (1)
Allergies (46)
Alliances (10656)
ALS (29)
Alzheimer's disease (387)
Antibody-drug conjugate (ADC) (68)
Approvals (4440)
Artificial intelligence (55)
Autoimmune disease (53)
Automation (3)
Bankruptcy (116)
Best Places to Work (3930)
BIOSECURE Act (2)
Biosimilars (36)
Biotechnology (4)
Bladder cancer (73)
Brain cancer (14)
Breast cancer (146)
Cancer (1357)
Cardiovascular disease (79)
Career advice (93)
Career pathing (1)
CAR-T (69)
CDC (2)
Cell therapy (176)
Cervical cancer (7)
Clinical research (21710)
Collaboration (351)
Compensation (171)
Complete response letters (10)
COVID-19 (344)
CRISPR (20)
C-suite (219)
Cystic fibrosis (55)
Data (2296)
Depression (44)
Diabetes (129)
Diagnostics (1542)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (39)
Drug pricing (16)
Duchenne muscular dystrophy (72)
Earnings (29053)
Editorial (2)
Employer branding (1)
Employer resources (8)
Events (22854)
Executive appointments (250)
FDA (5385)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (6)
Frontotemporal dementia (7)
Funding (217)
Gene editing (53)
Generative AI (2)
Gene therapy (126)
GLP-1 (146)
Government (564)
Guidances (245)
Healthcare (4208)
HIV (23)
Huntington's disease (4)
IgA nephropathy (44)
Immunology and inflammation (59)
Immuno-oncology (17)
Indications (27)
Infectious disease (410)
Inflammatory bowel disease (73)
Inflation Reduction Act (1)
Influenza (44)
Intellectual property (106)
Interviews (10)
IPO (5817)
IRA (3)
Job creations (421)
Job search strategy (78)
JPM (1)
Kidney cancer (7)
Labor market (2)
Layoffs (21)
Leadership (3)
Legal (1553)
Liver cancer (22)
Longevity (2)
Lung cancer (191)
Lymphoma (144)
Machine learning (6)
Management (3)
Manufacturing (155)
MASH (76)
Medical device (3186)
Medtech (3210)
Mergers & acquisitions (5519)
Metabolic disorders (322)
Multiple sclerosis (54)
NASH (5)
Neurodegenerative disease (51)
Neuropsychiatric disorders (16)
Neuroscience (658)
NextGen: Class of 2026 (1453)
Non-profit (921)
Now hiring (1)
Obesity (109)
Opinion (32)
Ovarian cancer (77)
Pain (54)
Pancreatic cancer (83)
Parkinson's disease (54)
Partnered (3)
Patents (185)
Patient recruitment (132)
Peanut (6)
People (15872)
Pharmaceutical (4)
Pharmacy benefit managers (5)
Phase 1 (6448)
Phase 2 (9305)
Phase 3 (7618)
Pipeline (2251)
Policy (21)
Postmarket research (642)
Preclinical (2303)
Press Release (1)
Prostate cancer (73)
Psychedelics (4)
Radiopharmaceuticals (53)
Rare diseases (247)
Real estate (932)
Recruiting (2)
Regulatory (6716)
Reports (8)
Research institute (341)
Resumes & cover letters (12)
Rett syndrome (21)
RSV (15)
Schizophrenia (50)
Series A (29)
Series B (18)
Service/supplier (2)
Sickle cell disease (29)
Special edition (4)
Spinal muscular atrophy (36)
Sponsored (2)
Startups (535)
State (1)
Supply chain (18)
Tariffs (2)
Vaccines (164)
Venture capital (5)
Weight loss (39)
Women's health (17)
Worklife (1)
Date
Today (31)
Last 7 days (161)
Last 30 days (547)
Last 365 days (9224)
2026 (976)
2025 (9255)
2024 (10782)
2023 (12347)
2022 (13238)
2021 (14857)
2020 (13982)
2019 (12782)
2018 (7431)
2017 (7808)
2016 (6531)
2015 (8802)
2014 (6085)
2013 (4198)
2012 (4850)
2011 (5294)
2010 (4665)
Location
Africa (128)
Alabama (10)
Arizona (45)
Arkansas (2)
Asia (10237)
Australia (1017)
California (3890)
Canada (471)
China (236)
Colorado (164)
Connecticut (174)
Delaware (50)
Europe (16159)
Florida (781)
Georgia (122)
Idaho (7)
Illinois (209)
India (12)
Indiana (238)
Iowa (1)
Japan (72)
Kansas (14)
Kentucky (3)
Louisiana (8)
Maine (45)
Maryland (475)
Massachusetts (2798)
Michigan (32)
Minnesota (190)
Missouri (20)
Montana (7)
Nebraska (6)
Nevada (38)
New Hampshire (33)
New Jersey (1371)
New Mexico (1)
New York (1153)
North Carolina (387)
North Dakota (1)
Northern California (1839)
Ohio (34)
Oklahoma (1)
Oregon (3)
Pennsylvania (919)
Puerto Rico (10)
Rhode Island (9)
South America (175)
South Carolina (40)
Southern California (1628)
Tennessee (70)
Texas (458)
United States (13881)
Utah (141)
Virginia (50)
Washington D.C. (24)
Washington State (318)
Wisconsin (3)
Wyoming (1)
168,471 Results for "199".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring
January 5, 2026
·
10 min read
Press Releases
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
December 19, 2025
·
5 min read
Press Releases
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter’s Option to Purchase Additional Shares
November 11, 2025
·
1 min read
BioMidwest
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia.
June 26, 2024
·
13 min read
BioCapital
KeViRx, Inc. Awarded $1.99 Million
KeViRx, Inc., an innovative, early-stage pharmaceutical company, announced the receipt of $1.99 million in grant funding from the U.S. Department of Defense’s Peer Reviewed Medical Research Program.
June 11, 2024
·
3 min read
Press Releases
Phanes Therapeutics announces first patient dosed in clinical study of mavrostobart (PT199) in combination with chemotherapy
May 27, 2025
·
2 min read
Press Releases
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
May 19, 2025
·
6 min read
Press Releases
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
Strong VINIA Momentum and New CDMO Win Delivers 39% Year-Over-Year GrowthCompany Fortifies Balance Sheet with Recent $19.9 Million Instiutional Equity Raise Following $14.7 Million Strengthening of Balance Sheet via Accelerated Warrant Exercises and Debt-to-Equity Conversions in September
November 13, 2025
·
14 min read
Press Releases
DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke
February 20, 2025
·
7 min read
Drug Development
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced the first patient being dosed in DiaMedica’s relaunch of its pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the treatment of acute ischemic stroke.
April 17, 2024
·
7 min read
1 of 16,848
Next
